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All-cause death 375(18.6％) 265(22.9％) 0.78(0.67-0.90) <0.001 0.91(0.77-1.09) 0.30
Cardiac death 230(11.3％) 230(11.3％) 0.82(0.68-1.00) 0.049 1.00(0.79-1.26) 0.99
Non-cardiac
death
145(8.2％) 103(10.4％) 0.71(0.56-0.90) 0.005 0.79(0.61-1.03) 0.09
MI 110(5.9％) 71(6.9％) 1.00(0.93-1.08) 0.32 0.89(0.65-1.22) 0.47
Stroke 100(5.4％) 70(6.9％) 0.75(0.56-1.00) 0.052 0.78(0.56-1.09) 0.15
Stent
thrombosis
51(2.7％) 30(2.8％) 0.95(0.62-1.49) 0.82 0.89(0.56-1.42) 0.61
TLR 423(22.2％) 272(25.6％) 0.85(0.73-0.99) 0.033 0.93(0.78-1.10) 0.40
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before coronary angiography. The primary endpoint was deﬁned as a signiﬁcant reduction
of IMR in thrombus aspiration compared to conventional PCI group.Myocardial perfusion
grade and resolution of ST-segment elevation were also assessed. Infarct size and left
ventricle remodeling were assessed by echocardiographic indices and SPECT.
Results: Manual thrombus aspiration, as compared with conventional PCI, resulted in
signiﬁcantly lower IMR (31.921.3 U vs. 47.035.8 U, P ¼ 0.0082). Treatment with
thrombus aspiration, as compared with conventional PCI, resulted in similar rates of
myocardial perfusion grade 0 or 1 (20.8% vs. 29.4%; relative risk, 0.71; 95% CI, 0.38
to 1.30; P¼0.26) and complete resolution of ST-segment elevation (59.7% vs. 47.1%;
relative risk, 1.27; 95% CI, 0.90 to 1.79, P¼0.17). In a multiple regression model with
the log-transformed IMR as dependent variable, after adjusting for clinical, angio-
graphic and procedural variables, thrombus aspiration remained a strong independent
predictor of lower IMR (27.14 U; 95% CI, 23.79 to 30.95 U, vs. 36.11 U; 95% CI,
30.74 to 42.41 U, P¼0.0076). Histopathological examination conﬁrmed successful
thrombus aspiration in 89.6% of patients.
Conclusions: Manual thrombus aspiration reduces microcirculatory resistance indi-
cating better myocardial perfusion compared to conventional PCI in patients with
STEMI. Manual thrombus aspiration tended towards improved clinical outcome.
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Background: It has been reported that thrombus aspiration is effective in STEMI
patients with total ischemic time duration of less than 3 hours and less effective in
longer ischemia. Some studies tested thrombus aspiration efﬁcacy only within 6 hours
from chest pain onset. However, little is known about invasive assessment of
thrombus aspiration efﬁcacy in STEMI patients beyond 6 hours of ischemia.
Methods: Patients who underwent thrombus aspiration were divided into two groups
according to total ischemic time duration:< 6 hours and6 hours. These patients were
taken from the PATA STEMI trial for the analysis. Primary endpoint was value of mean
index of microcirculatory resistance (IMR). Secondary endpoints were myocardial
blush grade (MBG), resolution of ST segment elevation, AUC CK, wall motion score
index (WMSI), left ventricular ejection fraction and MACE rate at one year follow-up.
Results: In the PATA STEMI trial 75 patients underwent manual thrombus aspiration
with the Eliminate3 catheter (Terumo Europe, Leiden, Belgium). In baseline charac-
teristics, patients delay (74,5 vs 377,9, P¼0,00018) and multivessel disease (46,0% vs
83,3%, P¼0,026) were more frequent in patients with total ischemic time 6 hours
(N¼12). In patients with totals ischemic time< 6 hours (N¼63) compared to those with
6 hours, mean IMR was 30,417,8 vs. 36,419,8 U, P¼0,34 (mean corrected IMR
26,515,8 vs. 34,319,9 U, P¼0,22), mean IMR in non-infarct related artery teritory
18,68,0 vs 24,24,0 U, P¼0,21, complete resolution of ST-segment elevation 63,5%
vs. 50%, P¼0,53, myocardial blush grade 2 in 80,9% vs. 66,7%, P¼0,44, AUC CK
4030325380 vs. 4443130316 U/L, P¼0,69, WMSI 1,320,33 vs. 1,180,19,
P¼0,06, LVEF 53,9% vs. 59,3%, P¼0,11 and MACE rate 11,1% vs. 0%, P¼0,59.
Conclusions: Manual thrombus aspiration in STEMI patients with ischemia lasting
less than 6 hours is similarly effective as in those with longer ischemia.
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Background: It has been reported that index of microcirculatory resistance (IMR) is
lower in STEMI patients who underwent thrombus aspiration before stent implantation
compared to those tretaed with conventional primary PCI. The aim of this study was to
evaluate impact of improved myocardial perfusion by manual thrombus aspiration
assessed by IMR on left ventricular remodeling in STEMI patients at mid-term follow-up.
Methods: The total of 115 patients entered the echocardiography substudy of the
PATA STEMI (randomized Physiologic Assessment of Thrombus Aspirtion in pa-
tients with ST-segment Elevation Myocardial Infarction) trial which evaluated eﬁcacy
of manual thrombus aspiration using Eliminate3 catheter (Terumo Europe, Leuven,
Belgium). Echocardiography was done within the ﬁrst 24 hours after the index pro-
cedure and after 4 months. End-diastolic and end-systolic left ventricular (LV) vol-
umes, ejection fraction (EF), cardiac sphericity index (CSI) and regional wall motion
score index (WMSI) were calculated.
Results: In baseline characteristics, in patients with thrombus aspiration compared to
those with conventional primary PCI, total ischemic time tended to be longer
246,7181,8 vs. 200,9110,1min, P¼0,09 andAUCCKwas smaller 4009026158U/L
vs. 5267632013 U/L, P¼0,026. Also, corrected IMR was lower in thrombus aspirationJACC Vol 64/11/Suppl B j September 13–17, 2014 j TCT Abstracts/Cagroup 27,516,8 vs. 39,932,7 U/L, p¼0,0079, while CFR (1,680,81 vs. 1,610,67,
P¼0,6) and mean capilary wedge pressure (20,46,6 vs. 21,47,8 mmHg, P¼0,5) were
similar. End-diastolic and end-systolic LV volumes per body surface area, EF, CSI volume
and WMSI were similar between the thrombus aspiration and no aspiration group at
baseline and at follow-up. At follow-up, percent change in WMSI tended to be greater in
thrombusaspirationgroup (decrease inWMSI8,2%vs. increase inWMSI0,8%,P¼0,094).
Conclusions: Improved myocardial perfusion assessed by IMR has no impact on left
ventricular remodeling in STEMI patients at mid-term follow-up.
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Background: The use of adjunctive thrombus aspiration (TA) promotes better cor-
onary reperfusion and improves myocardial perfusion in STEMI but the long-term
mortality beneﬁt still remains controversial.
Methods: The CREDO-Kyoto AMI registry is a large-scale cohort study of acute
myocardial infarction (AMI) patients undergoing coronary revascularization in 2005-
2007 at 26 hospitals in Japan. Among 5429 patients enrolled in the registry, the
current study population consisted of 3325 patients who arrived at the hospital within
12 hours after the symptom onset and underwent primary PCI. During primary PCI,
2120 out of 3325 (63.8%) patients received thrombus aspiration (the TA group).
Clinical outcomes were compared between the TA group and the non-TA group.
Results: The cumulativeﬁve-year incidence of all-cause deathwas signiﬁcantly lower in
the TA group than in the non-TA group (18.6% versus 22.6%, P< 0.001). Similarly, the
cumulative incidences of cardiac death, non-cardiac death, and target-lesion revascu-
larization (TLR) were signiﬁcantly lower in the TA group. After adjusting for
confounders, however, the use of adjunctive TA was not associated with lower risk for
all-cause death (hazard ratio [HR]:0.91, 95% conﬁdence interval [CI]:0.77-1.09,
P¼0.30). In contrast, the subgroup analysis indicated TAwas associated with a lower all-
causemortality only in patients with initial TIMI grade 1-3(HR: 0.70, 95%CI:0.52-0.94,
P¼0.02). Adjunctive thrombus aspiration had a neutral effect in the rest of the subgroups.Conclusions: Adjunctive thrombus aspiration was not associated with better ﬁve-year
mortality beneﬁt in STEMI patients who underwent primary PCI.Cath Lab of the Future
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